Article

Genomics of brain and blood: Progress and pitfalls

Department of Neurology and the M.I.N.D. Institute, University of California at Davis, Sacramento, California 95817, USA.
Epilepsia (Impact Factor: 4.58). 11/2006; 47(10):1603-7. DOI: 10.1111/j.1528-1167.2006.00809.x
Source: PubMed

ABSTRACT Gene expression profiles in brain and blood of animals and humans can be useful for diagnosis, prognosis, and treatment of epilepsy. This article reviews recent progress and prospects for the future.

Download full-text

Full-text

Available from: Donald L Gilbert, Dec 29, 2014
0 Followers
 · 
75 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer’s disease (AD) is the most common form of dementia, affecting millions of aging people worldwide with no known cure. Pathological analyses have identified extracellular β-amyloid plaques and intracellular neurofibrillary tangles of hyperphosphorylated tau as core features, but the key causal biochemical pathways remain elusive. In fact, functional genomic analyses suggest a number of other cellular changes occurring early in the disease, including synaptic and bio-energetic dysfunction, as well as a role for neuron–glia interactions. Given the complexity of AD and the limitations of our current knowledge, the field of AD research would benefit from taking hypothesis-independent approaches that allow one to view the data in a systems biology framework. This paradigm shift in AD transcriptional research would permit consolidation of the large body of often-conflicting transcriptional, proteomic, and other screening results into testable theories of AD progression. In this chapter, we will first review transcriptional studies of AD that use postmortem human brain, animal model systems, and peripheral human tissue, addressing the biological pathways that these studies suggest degrade with AD progression. Next, we will discuss recent studies with more multifaceted designs, and how results from such studies lend support to some of these theories. Finally, we will suggest how using a more systems-level approach to the study of AD could help scientists further clarify what goes wrong in the brain at various stages of AD progression and be beneficial for the development of more targeted therapies.
  • [Show abstract] [Hide abstract]
    ABSTRACT: We have investigated the inverted poly (3-hexylthiophene):methano-fullerene [6,6]-phenyl C71-butyric acid methyl ester (P3HT:PC71BM) bulk heterojunction (IBHJ) solar cell with various n-type metal oxide nano particle layers on ITO and MoO3 anode buffer layer underneath Al. The IBHJ solar cell with a tin oxide nano particle layer shows the power conversion efficiency (PCE) of 3.1% and better stability compared to conventional BHJ solar cell. The PCE of this cell decreases by 3% after 2 months in ambient air while the other cells show more degradation.
    Current Applied Physics 09/2012; 12. DOI:10.1016/j.cap.2011.04.034 · 2.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ischemic stroke provokes a systemic inflammatory response. The purpose of this study was to characterize this response on the gene expression level in circulating mononuclear leukocytes from acute ischemic stroke (AIS) patients. RNA from peripheral blood mononuclear cells (PBMCs) of AIS patients (24 + 2 hours after onset of symptoms) was analyzed with Affymetrix U133A GeneChips using a pooled design. We compared the gene expression signature from AIS patients (n = 20), stroke survivors (n = 15), patients with acute traumatic brain injury (ATBI, n = 15) and healthy control subjects without vascular risk factors (n = 15). Expression levels of 9682 probe sets with present calls on each GeneChip were compared. Between AIS patients and stroke survivors or between AIS patients and ATBI patients there were no significant differences in expression values of single genes after correction for multiple testing. However, comparison of the PBMC expression profiles from AIS patients and healthy subjects revealed significantly different expression (p = 0.012) of a single probe set, specific for phosphodiesterase 4 D (PDE4D). In order to detect modest expression differences in multiple genes with a presumed cumulative effect we studied the gene expression of functional groups of genes by global statistical tests. Analysis of 11 gene groups revealed differential expression between AIS patients and healthy subjects for genes involved in the inflammatory response (GeneOntology GO:0006954). Genes encoding the N-formyl peptide receptor-like 1 (FPRL1), interleukin-1 receptor antagonist (IL1RN) and complement component 3a receptor 1 (C3AR1) contributed most to the observed difference. This transcriptome analysis did not identify significant changes between circulating mononuclear cells from AIS patients 24 hours after stroke and closely matched stroke survivors. However, comparing AIS patients with healthy control subjects revealed measurable differences in PDE4D and in inflammatory response genes when considered as a set.
    Journal of Neurology 06/2008; 255(5):723-31. DOI:10.1007/s00415-008-0784-z · 3.84 Impact Factor
Show more